Sign in or create an account to add this stock to your watchlist.
About Avacta Group (LON:AVCT)
Avacta Group Plc offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. It operates through two segments, Life Sciences and Animal Health. The company's custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development. In addition, it provides tools and contract services to assist the diagnosis of conditions in animals to enable treatment for veterinarians. The company has a collaboration, licensing, and option agreement with Moderna Therapeutics; and a research collaboration with OncoSec Medical Incorporated for gene delivery of therapeutic Affimers. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
SymbolLON:AVCT
CUSIPN/A
Phone+44-1904-217070
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-199.59%
Return on Equity-18.76%
Return on Assets-17.83%
Miscellaneous
EmployeesN/A
Outstanding Shares68,400,000
Avacta Group (LON:AVCT) Frequently Asked Questions
What is Avacta Group's stock symbol?
Avacta Group trades on the London Stock Exchange (LON) under the ticker symbol "AVCT."
What price target have analysts set for AVCT?
0 Wall Street analysts have issued 12 month price targets for Avacta Group's shares. Their forecasts range from GBX 200 to GBX 200. On average, they anticipate Avacta Group's share price to reach GBX 200 in the next twelve months. View Analyst Ratings for Avacta Group.
Who are some of Avacta Group's key competitors?
Some companies that are related to Avacta Group include Hamilton Thorne (HTL), Kromek Group (KMK), Electromed (ELMD), Universal Biosensors (UBI), Advanced Oncotherapy (AVO), Protech Home Medical (PHM), MRI Interventions (MRIC), Surgical Innovations (SUN), NeuroOne Medical Tech (NMTC), PetVivo (PETV), Myomo (MYO), Airware Labs (AIRW), Inspiration Healthcare Group (IHC), HCi VioCare (VICA) and Micron Solutions (MICR).
Who are Avacta Group's key executives?
Avacta Group's management team includes the folowing people:
- Prof. Alastair Smith, CEO & Exec. Director
- Mr. Tony Gardiner, CFO, Company Sec. & Exec. Director (Age 47)
- Mr. Craig Slater, Chief Operating Officer of Avacta Animal Health (Age 55)
- Dr. Michael Albin, Adviser
- Dr. Matt Johnson, Chief Technology Officer
Has Avacta Group been receiving favorable news coverage?
Press coverage about AVCT stock has been trending somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Avacta Group earned a news sentiment score of 0.18 on Accern's scale. They also assigned media stories about the biotechnology company an impact score of 45.33 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
How do I buy shares of Avacta Group?
Shares of AVCT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Avacta Group's stock price today?
One share of AVCT stock can currently be purchased for approximately GBX 34.
How big of a company is Avacta Group?
Avacta Group has a market capitalization of £28.15 million.
How can I contact Avacta Group?
Avacta Group's mailing address is Unit 20, Ash Way, WETHERBY, LS23 7FA, United Kingdom. The biotechnology company can be reached via phone at +44-1904-217070.
MarketBeat Community Rating for Avacta Group (AVCT)
MarketBeat's community ratings are surveys of what our community members think about Avacta Group and other stocks. Vote "Outperform" if you believe AVCT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVCT will underperform the S&P 500 over the long term. You may vote once every thirty days.
Avacta Group (LON:AVCT) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | N/A | N/A | Buy | Buy |
| Consensus Rating Score: | N/A | N/A | 3.00 | 3.00 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | GBX 200 | GBX 200 | GBX 180 | GBX 180 |
Avacta Group (LON:AVCT) Consensus Price Target History
Avacta Group (LON:AVCT) Analyst Ratings History
Show:
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
| 5/22/2018 | FinnCap | Reiterated Rating | Corporate | |  |
| 4/4/2017 | Numis Securities | Reiterated Rating | Buy | GBX 160 | |
(Data available from 5/27/2016 forward)
Avacta Group (LON:AVCT) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Avacta Group (LON AVCT) Insider Trading and Institutional Ownership History
Avacta Group (LON AVCT) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/13/2018 | Alastair Smith | Insider | Buy | 35,800 | GBX 42 | £15,036 | | |
| 8/21/2017 | Alastair Smith | Insider | Buy | 33,225 | GBX 75 | £24,918.75 | | |
| 7/4/2017 | Michael Scott Albin | Insider | Buy | 4,345 | GBX 86 | £3,736.70 | | |
| 4/6/2017 | Michael Scott Albin | Insider | Buy | 5,731 | GBX 62 | £3,553.22 | | |
| 10/21/2016 | Mike Owen | Insider | Buy | 7,763 | GBX 90 | £6,986.70 | | |
| 7/7/2016 | Albin,Michael Scott | Insider | Buy | 3,393 | GBX 92 | £3,121.56 | | |
| 4/29/2016 | Slater ,Craig | Insider | Buy | 2,222 | GBX 113 | £2,510.86 | | |
| 4/6/2016 | Albin,Michael Scott | Insider | Buy | 899 | GBX 116 | £1,042.84 | | |
(Data available from 1/1/2013 forward)
Avacta Group (LON AVCT) News Headlines
| Source: |
|
Avacta Group (LON:AVCT) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Avacta Group (LON AVCT) Stock Chart for Sunday, May, 27, 2018
Loading chart…
